Literature DB >> 9790190

Destabilization of beta-catenin by mutations in presenilin-1 potentiates neuronal apoptosis.

Z Zhang1, H Hartmann, V M Do, D Abramowski, C Sturchler-Pierrat, M Staufenbiel, B Sommer, M van de Wetering, H Clevers, P Saftig, B De Strooper, X He, B A Yankner.   

Abstract

Mutations of the presenilin-1 gene are a major cause of familial early-onset Alzheimer's disease. Presenilin-1 can associate with members of the catenin family of signalling proteins, but the significance of this association is unknown. Here we show that presenilin-1 forms a complex with beta-catenin in vivo that increases beta-catenin stability. Pathogenic mutations in the presenilin-1 gene reduce the ability of presenilin-1 to stabilize beta-catenin, and lead to increased degradation of beta-catenin in the brains of transgenic mice. Moreover, beta-catenin levels are markedly reduced in the brains of Alzheimer's disease patients with presenilin-1 mutations. Loss of beta-catenin signalling increases neuronal vulnerability to apoptosis induced by amyloid-beta protein. Thus, mutations in presenilin-1 may increase neuronal apoptosis by altering the stability of beta-catenin, predisposing individuals to early-onset Alzheimer's disease.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9790190     DOI: 10.1038/27208

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  150 in total

Review 1.  Function and dysfunction of the presenilins.

Authors:  S S Sisodia; S H Kim; G Thinakaran
Journal:  Am J Hum Genet       Date:  1999-07       Impact factor: 11.025

Review 2.  Presenilins: structural aspects and posttranslational events.

Authors:  F Checler
Journal:  Mol Neurobiol       Date:  1999-06       Impact factor: 5.590

Review 3.  The role of presenilins in Alzheimer's disease.

Authors:  G Thinakaran
Journal:  J Clin Invest       Date:  1999-11       Impact factor: 14.808

Review 4.  The role of cell cycle-mediated events in Alzheimer's disease.

Authors:  A K Raina; M J Monteiro; A McShea; M A Smith
Journal:  Int J Exp Pathol       Date:  1999-04       Impact factor: 1.925

Review 5.  Roles of Wnt proteins in neural development and maintenance.

Authors:  A Patapoutian; L F Reichardt
Journal:  Curr Opin Neurobiol       Date:  2000-06       Impact factor: 6.627

6.  Amyloid angiopathy and variability in amyloid beta deposition is determined by mutation position in presenilin-1-linked Alzheimer's disease.

Authors:  D M Mann; S M Pickering-Brown; A Takeuchi; T Iwatsubo
Journal:  Am J Pathol       Date:  2001-06       Impact factor: 4.307

7.  A rescue factor abolishing neuronal cell death by a wide spectrum of familial Alzheimer's disease genes and Abeta.

Authors:  Y Hashimoto; T Niikura; H Tajima; T Yasukawa; H Sudo; Y Ito; Y Kita; M Kawasumi; K Kouyama; M Doyu; G Sobue; T Koide; S Tsuji; J Lang; K Kurokawa; I Nishimoto
Journal:  Proc Natl Acad Sci U S A       Date:  2001-05-22       Impact factor: 11.205

8.  Overexpression of beta-catenin induces apoptosis independent of its transactivation function with LEF-1 or the involvement of major G1 cell cycle regulators.

Authors:  K Kim; K M Pang; M Evans; E D Hay
Journal:  Mol Biol Cell       Date:  2000-10       Impact factor: 4.138

Review 9.  Presenilin: RIP and beyond.

Authors:  Matthew R Hass; Chihiro Sato; Raphael Kopan; Guojun Zhao
Journal:  Semin Cell Dev Biol       Date:  2008-11-27       Impact factor: 7.727

10.  GSK3β inhibition protects the immature brain from hypoxic-ischaemic insult via reduced STAT3 signalling.

Authors:  Barbara D'Angelo; C Joakim Ek; Yanyan Sun; Changlian Zhu; Mats Sandberg; Carina Mallard
Journal:  Neuropharmacology       Date:  2015-09-15       Impact factor: 5.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.